首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression
【24h】

Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression

机译:Dysbindin通过控制NMDA受体表面表达来调节海马LTP

获取原文
获取原文并翻译 | 示例
           

摘要

Abnormalities in NMDA receptor (NMDAR) function have been implicated in schizophrenia. Here, we show that dysbindin, a schizophrenia-susceptibility gene widely expressed in the fore-brain, controls the surface expression of NMDARs in a subunit-specific manner. Imaging analyses revealed a marked increase in surface NR2A, but not NR2B, in hippocampal neurons derived from dysbindin-null mutant mice (Dys-/-). Exogenous expression of dysbindin reduced NR2A surface expression in both wild-type and Dys-/- neurons. Biotinylation experiments also revealed an increase in surface expression of endogenous NR2A in Dys-/-neurons. Disruption of the dysbindin gene dramatically increased NR2A-mediated synaptic currents, without affecting AMPA receptor currents, in hippocampal CA1 neurons. The Dys-/- hippocampal slices exhibited an enhanced LTP, whereas basal synaptic transmission, presynaptic properties, and LTD were normal. Thus, dysbindin controls hippocampal LTP by selective regulation of the surface expression of NR2A. These results reveal subunit-specific regulation of NMDARs by dysbindin, providing an unexpected link between these two proteins implicated in schizophrenia.
机译:NMDA受体(NMDAR)功能异常与精神分裂症有关。在这里,我们显示dysbindin,一种在前脑中广泛表达的精神分裂症易感基因,以亚单位特异性方式控制NMDARs的表面表达。成像分析显示,源自dysbindin-null突变小鼠(Dys-/-)的海马神经元表面NR2A明显增加,但NR2B没有明显增加。 dysbindin的外源表达降低了野生型和Dys-/-神经元中的NR2A表面表达。生物素化实验还揭示了Dys //-神经元中内源性NR2A的表面表达增加。 dysbindin基因的破坏大大增加了海马CA1神经元中NR2A介导的突触电流,而不影响AMPA受体电流。 Dys //-海马切片表现出增强的LTP,而基础突触传递,突触前特性和LTD正常。因此,dysbindin通过选择性调节NR2A的表面表达来控制海马LTP。这些结果揭示了dysbindin对NMDAR的亚基特异性调控,在精神分裂症的这两种蛋白之间提供了意想不到的联系。

著录项

  • 来源
  • 作者单位

    Receptor Biology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3714 Medical Research Council Centre for Synaptic Plasticity, Department of Anatomy, University of Bristol, School of Medical Sciences, Bristol BS8 1TD, United Kingdom;

    Section on Neural Development and Plasticity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-3714;

    Receptor Biology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3714;

    Gene, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-3714;

    Section on Neural Development and Plasticity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-3714;

    Receptor Biology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-3714;

    Section on Neural Development and Plasticity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-3714 Gene, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-3714;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    glutamate receptor; schizophrenia; synaptic plasticity;

    机译:谷氨酸受体;精神分裂症;突触可塑性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号